Rankings
▼
Calendar
MYGN FY 2025 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena
MYGN
Myriad Genetics, Inc.
$487M
FY 2025 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$825M
-1.6% YoY
Gross Profit
$577M
69.9% margin
Operating Income
-$139M
-16.9% margin
Net Income
-$366M
-44.4% margin
EPS (Diluted)
$-3.96
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$2M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$707M
Total Liabilities
$339M
Stockholders' Equity
$368M
Cash & Equivalents
$150M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$825M
$838M
-1.6%
Gross Profit
$577M
$585M
-1.5%
Operating Income
-$139M
-$124M
-12.8%
Net Income
-$366M
-$127M
-187.4%
← Q4 2024
All Quarters
Q1 2025 →